Akin Gump Advises Baker Bros. in Leap Therapeutics Investment
Contact:
(New York) – Akin Gump advised Baker Bros. Advisors LP in the purchase by its affiliates of Series A mandatorily convertible preferred stock of Leap Therapeutics, Inc. Baker Bros. acted as the lead investor in the transaction.
Upon approval by the Leap stockholders, the Series A mandatorily convertible preferred stock will automatically convert into pre-funded warrants to purchase 14,218,010 shares of Leap common stock. Upon stockholder approval and conversion of the preferred stock, Baker Bros. will also receive warrants to purchase up to an equal number of shares of common stock.
The Akin Gump team advising Baker Bros. was led by corporate practice head Jeffrey Kochian. He was joined by counsel Alyssa Dossick, Anthony Ameduri and Yehuda Raskin as well as investment management partner Jason Daniel and tax partner Olivier De Moor.
Akin Gump Strauss Hauer & Feld LLP is a leading international law firm with more than 1,000 lawyers and advisors in offices throughout the United States, Europe, Asia and the Middle East.
# # #
